2024-12-23 12:12:56
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program
Health/ 2023-07-22
I-Mab and CSPC Pharma Announce Strategic...

SHANGHAI,Dec. 17,2018-- I-Mab Biopharma ("I-Mab"),a China-based clinical stage biopharmaceutical company focused on the developmen...

NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)
Health/ 2023-07-22
NeuClone Announces its Sixth Biosimilar ...

SYDNEY,Dec. 17,2018-- NeuClone Pharmaceuticals Ltd. (NeuClone),a clinical-stage biopharmaceutical company exclusively focused on developing ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release